Literature DB >> 22390970

Into the eye of the cytokine storm.

Jennifer R Tisoncik1, Marcus J Korth, Cameron P Simmons, Jeremy Farrar, Thomas R Martin, Michael G Katze.   

Abstract

The cytokine storm has captured the attention of the public and the scientific community alike, and while the general notion of an excessive or uncontrolled release of proinflammatory cytokines is well known, the concept of a cytokine storm and the biological consequences of cytokine overproduction are not clearly defined. Cytokine storms are associated with a wide variety of infectious and noninfectious diseases. The term was popularized largely in the context of avian H5N1 influenza virus infection, bringing the term into popular media. In this review, we focus on the cytokine storm in the context of virus infection, and we highlight how high-throughput genomic methods are revealing the importance of the kinetics of cytokine gene expression and the remarkable degree of redundancy and overlap in cytokine signaling. We also address evidence for and against the role of the cytokine storm in the pathology of clinical and infectious disease and discuss why it has been so difficult to use knowledge of the cytokine storm and immunomodulatory therapies to improve the clinical outcomes for patients with severe acute infections.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22390970      PMCID: PMC3294426          DOI: 10.1128/MMBR.05015-11

Source DB:  PubMed          Journal:  Microbiol Mol Biol Rev        ISSN: 1092-2172            Impact factor:   11.056


  158 in total

Review 1.  Averting inflammation by targeting the cytokine environment.

Authors:  Manfred Kopf; Martin F Bachmann; Benjamin J Marsland
Journal:  Nat Rev Drug Discov       Date:  2010-09       Impact factor: 84.694

2.  Lethal dissemination of H5N1 influenza virus is associated with dysregulation of inflammation and lipoxin signaling in a mouse model of infection.

Authors:  Cristian Cilloniz; Mary J Pantin-Jackwood; Chester Ni; Alan G Goodman; Xinxia Peng; Sean C Proll; Victoria S Carter; Elizabeth R Rosenzweig; Kristy J Szretter; Jacqueline M Katz; Marcus J Korth; David E Swayne; Terrence M Tumpey; Michael G Katze
Journal:  J Virol       Date:  2010-05-26       Impact factor: 5.103

3.  Upregulation of the chemokine (C-C motif) ligand 2 via a severe acute respiratory syndrome coronavirus spike-ACE2 signaling pathway.

Authors:  I-Yin Chen; Shin C Chang; Hung-Yi Wu; Ting-Chun Yu; Wen-Chin Wei; Shiming Lin; Chung-Liang Chien; Ming-Fu Chang
Journal:  J Virol       Date:  2010-05-19       Impact factor: 5.103

Review 4.  Host response to influenza virus: protection versus immunopathology.

Authors:  J S M Peiris; Kenrie P Y Hui; Hui-Ling Yen
Journal:  Curr Opin Immunol       Date:  2010-06-30       Impact factor: 7.486

5.  Mice lacking both TNF and IL-1 receptors exhibit reduced lung inflammation and delay in onset of death following infection with a highly virulent H5N1 virus.

Authors:  Lucy A Perrone; Kristy J Szretter; Jacqueline M Katz; Joseph P Mizgerd; Terrence M Tumpey
Journal:  J Infect Dis       Date:  2010-10-15       Impact factor: 5.226

6.  Transcriptomic analysis reveals a mechanism for a prefibrotic phenotype in STAT1 knockout mice during severe acute respiratory syndrome coronavirus infection.

Authors:  Gregory A Zornetzer; Matthew B Frieman; Elizabeth Rosenzweig; Marcus J Korth; Carly Page; Ralph S Baric; Michael G Katze
Journal:  J Virol       Date:  2010-08-11       Impact factor: 5.103

Review 7.  PPAR-gamma activation as an anti-inflammatory therapy for respiratory virus infections.

Authors:  Josep Bassaganya-Riera; Rong Song; Paul C Roberts; Raquel Hontecillas
Journal:  Viral Immunol       Date:  2010-08       Impact factor: 2.257

8.  Monocyte chemoattractant protein 1 contributes to an adequate immune response in influenza pneumonia.

Authors:  Mark C Dessing; Koenraad F van der Sluijs; Sandrine Florquin; Tom van der Poll
Journal:  Clin Immunol       Date:  2007-09-10       Impact factor: 3.969

9.  Timing of CD8+ T cell responses in relation to commencement of capillary leakage in children with dengue.

Authors:  Nguyen Thi Phuong Dung; Huynh Thi Le Duyen; Nguyen Thi Van Thuy; Tran Van Ngoc; Nguyen Van Vinh Chau; Tran Tinh Hien; Sarah L Rowland-Jones; Tao Dong; Jeremy Farrar; Bridget Wills; Cameron P Simmons
Journal:  J Immunol       Date:  2010-05-12       Impact factor: 5.422

10.  Pharmacologic inhibition of COX-1 and COX-2 in influenza A viral infection in mice.

Authors:  Michelle A Carey; J Alyce Bradbury; Yvette D Rebolloso; Joan P Graves; Darryl C Zeldin; Dori R Germolec
Journal:  PLoS One       Date:  2010-07-15       Impact factor: 3.240

View more
  667 in total

1.  CCR2 Signaling Selectively Regulates IFN-α: Role of β-Arrestin 2 in IFNAR1 Internalization.

Authors:  Dionna W Williams; Lauren C Askew; Elonna Jones; Janice E Clements
Journal:  J Immunol       Date:  2018-11-30       Impact factor: 5.422

Review 2.  Immunometabolism: Another Road to Sepsis and Its Therapeutic Targeting.

Authors:  Vijay Kumar
Journal:  Inflammation       Date:  2019-06       Impact factor: 4.092

3.  Mutations during the Adaptation of H9N2 Avian Influenza Virus to the Respiratory Epithelium of Pigs Enhance Sialic Acid Binding Activity and Virulence in Mice.

Authors:  W Yang; D Punyadarsaniya; R L O Lambertz; D C C Lee; C H Liang; D Höper; S R Leist; A Hernández-Cáceres; J Stech; M Beer; C Y Wu; C H Wong; K Schughart; F Meng; G Herrler
Journal:  J Virol       Date:  2017-03-29       Impact factor: 5.103

Review 4.  Systems-level analysis of innate immunity.

Authors:  Daniel E Zak; Vincent C Tam; Alan Aderem
Journal:  Annu Rev Immunol       Date:  2014       Impact factor: 28.527

Review 5.  Acute Inflammation and Metabolism.

Authors:  Miguel Lourenço Varela; Mihail Mogildea; Ignacio Moreno; Ana Lopes
Journal:  Inflammation       Date:  2018-08       Impact factor: 4.092

6.  Repeated PD-1/PD-L1 monoclonal antibody administration induces fatal xenogeneic hypersensitivity reactions in a murine model of breast cancer.

Authors:  Christine Mall; Gail D Sckisel; David A Proia; Annie Mirsoian; Steven K Grossenbacher; Chien-Chun Steven Pai; Mingyi Chen; Arta M Monjazeb; Karen Kelly; Bruce R Blazar; William J Murphy
Journal:  Oncoimmunology       Date:  2015-08-12       Impact factor: 8.110

7.  Matrix metalloproteinase-9 deficiency protects mice from severe influenza A viral infection.

Authors:  Joselyn Rojas-Quintero; Xiaoyun Wang; Jennifer Tipper; Patrick R Burkett; Joaquin Zuñiga; Amit R Ashtekar; Francesca Polverino; Amit Rout; Ilyas Yambayev; Carmen Hernández; Luis Jimenez; Gustavo Ramírez; Kevin S Harrod; Caroline A Owen
Journal:  JCI Insight       Date:  2018-12-20

Review 8.  Innate immunity to influenza virus infection.

Authors:  Akiko Iwasaki; Padmini S Pillai
Journal:  Nat Rev Immunol       Date:  2014-05       Impact factor: 53.106

9.  Antiviral potential of ERK/MAPK and PI3K/AKT/mTOR signaling modulation for Middle East respiratory syndrome coronavirus infection as identified by temporal kinome analysis.

Authors:  Jason Kindrachuk; Britini Ork; Brit J Hart; Steven Mazur; Michael R Holbrook; Matthew B Frieman; Dawn Traynor; Reed F Johnson; Julie Dyall; Jens H Kuhn; Gene G Olinger; Lisa E Hensley; Peter B Jahrling
Journal:  Antimicrob Agents Chemother       Date:  2014-12-08       Impact factor: 5.191

10.  Effect of statin treatments on highly pathogenic avian influenza H5N1, seasonal and H1N1pdm09 virus infections in BALB/c mice.

Authors:  Yohichi Kumaki; John D Morrey; Dale L Barnard
Journal:  Future Virol       Date:  2012-08       Impact factor: 1.831

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.